Hepatitis C: Exploring an Epidemic and New Treatment Options

Wednesday, January 20, 2016 - Friday, January 20, 2017 12:00 AM   Online, IN

Directly Provided - Enduring Materials Internet 


At the conclusion of this activity, participants should be able to:

  1. Identify risk factors for transmission of hepatitis C virus (HCV);
  2. Recall the pathophysiology of HCV infection and the consequence of chronic disease progression;
  3. List new direct-acting antivirals (DAAs), the mechanism of action and associated side effects; and
  4. Explore issues surrounding the high cost of HCV infection treatment.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Indiana University School of Medicine and Indiana University Health Bloomington Hospital.  The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement 
Indiana University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For questions about accessibility or to request accommodations please contact the CME office at 317-274-0104 or cme@iu.edu. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.